Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Drug Metabolism and Pharmacokinetics (DMPK) Service Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Drug Metabolism and Pharmacokinetics (DMPK) Service help support drug developers in understanding the Absorption, Distribution, Metabolism, and Excretion (ADME) processes of specific compounds or drugs. DMPK projects cover a drug development program from the discovery, candidate selection, Investigational New Drug (IND) enabling, through New Drug Application (NDA) stages. ADME is a subset of DMPK, focusing on the absorption, distribution, metabolism, and excretion of drugs. In addition to ADME, DMPK adds pharmacokinetics including considerations of dosage regimens, optimal dosage frequencies, and factors affecting drug efficacy and safety. DMPK studies are crucial in evaluating the pharmacokinetic behavior of potential drug candidates, optimizing dosing regimens, and bridging their safety and efficacy before advancing to later stages of development. DMPK studies include a range of in vitro and in vivo assays to understand how the body interacts with a drug or compound. To be more specific, these studies include in vitro ADME (Absorption, Distribution, Metabolism, and Excretion), rodent pharmacokinetics, large animal pharmacokinetics, metabolites profiling and identification, mass balance and tissue distribution, etc.

According to our (Global Info Research) latest study, the global Drug Metabolism and Pharmacokinetics (DMPK) Service market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Drug Metabolism and Pharmacokinetics (DMPK) Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Drug Metabolism and Pharmacokinetics (DMPK) Service market size and forecasts, in consumption value ($ Million), 2019-2030

Global Drug Metabolism and Pharmacokinetics (DMPK) Service market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Drug Metabolism and Pharmacokinetics (DMPK) Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Drug Metabolism and Pharmacokinetics (DMPK) Service market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Drug Metabolism and Pharmacokinetics (DMPK) Service

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Drug Metabolism and Pharmacokinetics (DMPK) Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NuChem Sciences Inc, Sygnature Discovery, Paraza Pharma, Inc, Dalriada, Inotiv, Eurofins Discovery, RTI International, Frontage Labs, Labcorp, Jubilant Biosys, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Drug Metabolism and Pharmacokinetics (DMPK) Service market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Drug Metabolism and Pharmacokinetics (DMPK) Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
In Vivo Drug Metabolism and Pharmacokinetics Services
In Vitro Drug Metabolism and Pharmacokinetics Services

Market segment by Application
Pharmaceutical Research and Development
Biotechnology
Efficacy Testing
Others

Market segment by players, this report covers
NuChem Sciences Inc
Sygnature Discovery
Paraza Pharma, Inc
Dalriada
Inotiv
Eurofins Discovery
RTI International
Frontage Labs
Labcorp
Jubilant Biosys
Creative Biolabs
Evotec
Charles River
Anthem Bio Sciences
Molecular Diagnostic Services, Inc
Invitrocue
TCG Lifesciences Private Limited
Q 2 Solutions
WuXi AppTec
oncodesign service
Alliance Pharma, Inc
QPS Holdings
NUVISAN

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Drug Metabolism and Pharmacokinetics (DMPK) Service product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Drug Metabolism and Pharmacokinetics (DMPK) Service, with revenue, gross margin, and global market share of Drug Metabolism and Pharmacokinetics (DMPK) Service from 2019 to 2024.

Chapter 3, the Drug Metabolism and Pharmacokinetics (DMPK) Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Drug Metabolism and Pharmacokinetics (DMPK) Service market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Metabolism and Pharmacokinetics (DMPK) Service.

Chapter 13, to describe Drug Metabolism and Pharmacokinetics (DMPK) Service research findings and conclusion.